Lisa Walter
Stock Analyst at RBC Capital
(2.33)
# 2,704
Out of 5,042 analysts
5
Total ratings
50%
Success rate
14.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Reiterates: Outperform | $26 | $11.34 | +129.28% | 1 | Oct 21, 2025 | |
| UTHR United Therapeutics | Initiates: Outperform | $569 | $418.58 | +35.94% | 1 | Sep 26, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Outperform | $45 → $41 | $22.16 | +85.02% | 1 | Aug 7, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Sector Perform | $17 → $19 | $28.17 | -32.55% | 1 | Aug 1, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Outperform | $28 | $11.98 | +133.72% | 1 | Jun 17, 2025 |
4D Molecular Therapeutics
Oct 21, 2025
Reiterates: Outperform
Price Target: $26
Current: $11.34
Upside: +129.28%
United Therapeutics
Sep 26, 2025
Initiates: Outperform
Price Target: $569
Current: $418.58
Upside: +35.94%
Viridian Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $41
Current: $22.16
Upside: +85.02%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Sector Perform
Price Target: $17 → $19
Current: $28.17
Upside: -32.55%
EyePoint Pharmaceuticals
Jun 17, 2025
Initiates: Outperform
Price Target: $28
Current: $11.98
Upside: +133.72%